A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

  • Glaspole, Ian (Primary Chief Investigator (PCI))
  • Symons, Karen (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date30/08/21 → 31/12/24

Keywords

  • Respiratory diseases
  • Idiopathic pulmonary fibrosis
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)